EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

INFLUENCE OF LONG-TERM APPLICATION OF ANTI-HYPERTENSIVE DRUGS AND CONDUCTING THE "SCHOOL OF HYPERTENSION" ON THE DEVELOPMENT OF RISK OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ARTERIAL HYPERTENSION

*D. Z.Yarmukhamedova, N.B.Nuritdinova, Z.M.Shoalimova, M.S.Makhmudova, S.M.Shukurdjanova, M.?.Zubaydullaeva

ABSTRACT

To assess the impact of long-term use of antihypertensive drugs and the "school of hypertension" on the development of the risk of cardiovascular complications and quality of life in patients with arterial hypertension, 610 patients with AH of 1–2 degrees were examined. The duration of hypertension was 6.8 ± 1.6 years. Of the 610 patients examined, 231 (37.9%) were patients with degree I hypertension (mean age of patients was 46.7 ± 7.0 years) and 379 (62.1%) - with degree 2 hypertension (mean age 49.1 +6.92 years). Patients with grade 1 hypertension began to take 10 mg of enalapril per day as monotherapy (Enap, KRKA, Slovenia). Patients with grade 2 hypertension were divided into 2 groups, taking into account risk stratification. Group 1 (medium risk) took 10 mg of enalapril per day, group 2 (medium and high risk) started taking enalapril 12.5 mg with hydrochlorothiazide - a fixed combination - Enap HL. Analysis of the results of the study showed that after 4 weeks of taking enalapril there was a decrease in blood pressure from 158.2 ± 6.5 / 96.1 ± 4.9 to 142.2 ± 7.1 / 88.1 ± 5.9 mm Hg. Art. (p <0.001), 22% of patients reached the target blood pressure. At the same time, in the group taking Enap HL, blood pressure decreased from 159.6 ± 6.4 / 97.5 ± 3.8 to 139.4 ± 8.7 / 87.4 ± 7.1 mm Hg. Art. (p <0.0001). Assessment of patients the occurrence of cardiovascular complications in patients with AH of 1 degree with a high risk of 16.9%, with a very high risk of 1.7%, and in patients with AH of 2 degrees, this condition was 33% and 12.4%, respectively.

Keywords: arterial hypertension, cardiovascular risk, fixed combination, school-hypertension.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: APRIL ISSUE PUBLISHED

    APRIL Issue has been successfully launched on 1 April 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )